|
|
|
|
|
by SiVal
2257 days ago
|
|
When the clinical demand wanes, I hope there will be extensive antibody testing in various regions to do a comparison between how many people actually got it vs. how much damage it did. If, as I suspect, there are significant differences (ex: almost everyone in this town seems to have the antibodies, but nobody died, vs. a third of these people have the antibodies, but a lot of people died), we might be able to learn things such as which public policy decisions mattered most and maybe even which ethnicities are more vulnerable or resistant genetically. If a genetic variation is found, it might even lead to a new generation of preventative therapies that go beyond vaccines to shield people against viruses that don't even exist yet. |
|
There are a million reason for differences like that, without studying the problem extremely carefully, you'll never know which of those reasons was consequential. For instance, more people may die in a certain city because there is more pollution in the air, or the concentration of fluoride in the city's water supply is higher, or maybe that city houses a large meat packing plant and an abnormally large number of residents had to roll the dice and work throughout the lockdown. The number of possibilities are nearly endless, and you'd need to eliminate them prior to drawing any conclusions.
Even ethnically, you can't really draw any conclusions. Were people of this ethnicity or that ethnicity more likely to be essential Walmart stockboys than others? That one little detail can have an enormous impact on medical outcomes depending on the contagiousness of a pathogen like covid-19.
To draw any reasonable conclusions, you'd really need far more than just a comparison between regions, because the different regions have such different public health needs and environmental realities. You'd even need more than a simple comparison between ethnicities. You would need to go wayyy more deep. But I can guarantee that researchers will dig deep to find anything that can be used attack similar pathogens in the future.